Literature DB >> 10813258

Worldwide epidemiology of chronic obstructive pulmonary disease.

J C Chen1, D M Mannino.   

Abstract

Chronic obstructive pulmonary disease (COPD) continues to cause a heavy health and economic burden around the world. Recent studies have added evidence to the etiologic role of known and suspected risk factors for lung function decline and COPD, including smoking, occupational exposures, air pollution, airway hyperresponsiveness, and certain genetic variations. Among most populations, COPD prevalence and mortality are still increasing and will likely continue to rise in response to increases in smoking, particularly by women and adolescents. Resources aimed at smoking cessation and prevention and the early detection of COPD will be of the most benefit in our continuing efforts against this important cause of morbidity and mortality.

Entities:  

Mesh:

Year:  1999        PMID: 10813258     DOI: 10.1097/00063198-199903000-00003

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  17 in total

1.  Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008.

Authors:  Divay Chandra; Jason A Stamm; Brian Taylor; Rose Mary Ramos; Lewis Satterwhite; Jerry A Krishnan; David Mannino; Frank C Sciurba; Fernando Holguín
Journal:  Am J Respir Crit Care Med       Date:  2011-10-20       Impact factor: 21.405

Review 2.  Integrative Medicine for Respiratory Conditions: Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Gloria Y Yeh; Randy Horwitz
Journal:  Med Clin North Am       Date:  2017-06-21       Impact factor: 5.456

3.  A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies.

Authors:  Chelsea Taylor; Clayton W Commander; Joseph M Collaco; Lisa J Strug; Weili Li; Fred A Wright; Aaron D Webel; Rhonda G Pace; Jaclyn R Stonebraker; Kathleen Naughton; Ruslan Dorfman; Andrew Sandford; Scott M Blackman; Yves Berthiaume; Peter Paré; Mitchell L Drumm; Julian Zielenski; Peter Durie; Garry R Cutting; Michael R Knowles; Mary Corey
Journal:  Pediatr Pulmonol       Date:  2011-04-01

4.  Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

Authors:  David M Mannino; A Sonia Buist; William M Vollmer
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

5.  Behavioral medicine approaches to chronic obstructive pulmonary disease.

Authors:  Andreas von Leupoldt; Anja Fritzsche; Ana F Trueba; Alicia E Meuret; Thomas Ritz
Journal:  Ann Behav Med       Date:  2012-08

6.  Pharmacokinetics of the novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide in the rat.

Authors:  Zaineb A Fadhel Albayati; Linda P Dwoskin; Peter A Crooks
Journal:  Drug Metab Dispos       Date:  2008-07-10       Impact factor: 3.922

7.  Molecular biomarkers for quantitative and discrete COPD phenotypes.

Authors:  Soumyaroop Bhattacharya; Sorachai Srisuma; Dawn L Demeo; Steven D Shapiro; Raphael Bueno; Edwin K Silverman; John J Reilly; Thomas J Mariani
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-10       Impact factor: 6.914

8.  Lung function decline and outcomes in an elderly population.

Authors:  D M Mannino; K J Davis
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

9.  Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey.

Authors:  D M Mannino; F Holguin; H M Greves; A Savage-Brown; A L Stock; R L Jones
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

10.  Peripheral blood gene expression profiles in COPD subjects.

Authors:  Soumyaroop Bhattacharya; Shivraj Tyagi; Sorachai Srisuma; Dawn L Demeo; Steven D Shapiro; Raphael Bueno; Edwin K Silverman; John J Reilly; Thomas J Mariani
Journal:  J Clin Bioinforma       Date:  2011-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.